Literature DB >> 16557603

Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population.

Ute Amann1, Veronika Egen-Lappe, Christine Strunz-Lehner, Joerg Hasford.   

Abstract

PURPOSE: Antibiotics are frequently prescribed drugs in pregnancy. The purpose of the study was to analyse the use, the potential risks and the determinants of systemic antibiotic prescriptions during pregnancy.
METHODS: A large, nation-wide acting German statutory sickness fund provided prescription data and personal data of 41,293 pregnant women. For this study, all prescriptions of systemic antibiotics (ATC: J01) dispensed to each woman during a 21-month period were analysed. We used the FDA risk classification system and enrolled a literature search to identify potentially harmful antibiotics. To investigate the impact of geographical and socio-economic determinants in antibiotic prescribing, a multivariate logistic regression model was performed.
RESULTS: Of the 41,293 women, 19.7% received at least one antibiotic drug during pregnancy. There was a shift to relatively safe and reduced antibiotic drug use during pregnancy. Prescribing of contraindicated antibactericals or potentially harmful drugs was seen in 521 women (1.3% of all women). In the logistic regression, being younger than 21 years (adjusted OR 2.14, 95%CI 1.80-2.53) or being welfare recipient (adjusted OR 1.57, CI 1.25-2.00) was strongly associated with higher antibiotic use. Significantly lower antibiotic use was seen in 5 of 16 German federal states (OR 0.74-0.83).
CONCLUSIONS: About 20% of pregnant women received antibiotics, and 1.3% received a harmful drug. To minimise the risks, detailed guidelines are needed for the antibiotic treatment during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557603     DOI: 10.1002/pds.1225

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  15 in total

1.  Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

Authors:  Anders Engeland; Jørgen G Bramness; Anne Kjersti Daltveit; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

2.  Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy.

Authors:  Joshua J Gagne; Vittorio Maio; Vincenzo Berghella; Daniel Z Louis; Joseph S Gonnella
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

Review 3.  [Drug therapy of otorhinolaryngological diseases in pregnancy : An update].

Authors:  R Riepl; U Friebe-Hoffmann
Journal:  HNO       Date:  2016-11       Impact factor: 1.284

4.  Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation.

Authors:  Marie-Pierre Gendron; Brigitte Martin; Driss Oraichi; Anick Bérard
Journal:  Eur J Clin Pharmacol       Date:  2009-01-24       Impact factor: 2.953

5.  Impacts of ceftriaxone exposure during pregnancy on maternal gut and placental microbiota and its influence on maternal and offspring immunity in mice.

Authors:  Ruyue Cheng; Jiawen Guo; Yujie Zhang; Guo Cheng; Wei Qian; ChaoMin Wan; Ming Li; Francesco Marotta; Xi Shen; Fang He
Journal:  Exp Anim       Date:  2020-12-03

6.  Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark.

Authors:  Anne-Mette Bay Bjørn; Mette Nørgaard; Heidi Holmager Hundborg; Ellen Aagaard Nohr; Vera Ehrenstein
Journal:  Clin Epidemiol       Date:  2011-05-02       Impact factor: 4.790

7.  Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register.

Authors:  Olof Stephansson; Fredrik Granath; Tobias Svensson; Bengt Haglund; Anders Ekbom; Helle Kieler
Journal:  Clin Epidemiol       Date:  2011-02-01       Impact factor: 4.790

8.  Antibiotic use amongst pregnant women in a public hospital in KwaZulu-Natal.

Authors:  Sasha Naidoo; Varsha Bangalee; Frasia Oosthuizen
Journal:  Health SA       Date:  2021-05-31

9.  Socioeconomic Status and Determinants of Pediatric Antibiotic Use.

Authors:  Andrew McGurn; Brittany Watchmaker; Kaavya Adam; Jeff Ni; Piotr Babinski; Hannah Friedman; Bridget Boyd; Lara R Dugas; Talar Markossian
Journal:  Clin Pediatr (Phila)       Date:  2020-08-04       Impact factor: 1.168

10.  Prevalence and predictors of antibiotic administration during pregnancy and birth.

Authors:  Jakob Stokholm; Susanne Schjørring; Louise Pedersen; Anne Louise Bischoff; Nilofar Følsgaard; Charlotte G Carson; Bo L K Chawes; Klaus Bønnelykke; Anne Mølgaard; Karen A Krogfelt; Hans Bisgaard
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.